I have been taking lorazepam (Ativan) 1 mg daily for 6 weeks; can I stop it abruptly (cold turkey)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No, Do Not Stop Lorazepam Cold Turkey After 6 Weeks of Daily Use

You should NOT stop lorazepam (Ativan) 1 mg abruptly after 6 weeks of daily use—gradual tapering is essential to prevent potentially serious withdrawal complications including seizures, hallucinations, delirium, and in rare cases, death 1, 2, 3.

Why Abrupt Discontinuation Is Dangerous

After 6 weeks of daily benzodiazepine use, your body has developed physiological dependence. The FDA drug label for Ativan explicitly warns that abrupt discontinuation can precipitate acute withdrawal reactions that can be life-threatening 3. Multiple clinical guidelines confirm that benzodiazepines should be tapered gradually when discontinued because abrupt withdrawal can cause 1, 2:

  • Seizures (potentially life-threatening)
  • Rebound anxiety and panic attacks
  • Hallucinations
  • Delirium tremens
  • Altered mental status
  • In rare cases, death

Even at your relatively modest dose of 1 mg daily for 6 weeks, withdrawal symptoms can occur. Research demonstrates that withdrawal seizures have been reported with as little as 15 days of therapeutic dosage use 4.

Recommended Tapering Approach

The standard safe tapering schedule is a reduction of 25% of the benzodiazepine dose every 1-2 weeks 1, 2. For your situation with lorazepam 1 mg daily:

Specific Taper Schedule:

  • Weeks 1-2: Reduce to 0.75 mg daily (25% reduction)
  • Weeks 3-4: Reduce to 0.5 mg daily (50% of original dose)
  • Weeks 5-6: Reduce to 0.25 mg daily (25% of original dose)
  • Week 7: Discontinue completely

This gradual approach minimizes withdrawal symptoms while allowing your nervous system to readjust. The pediatric guidelines suggest even more conservative approaches with 10-20% reductions per day for lorazepam weaning 5, though adult tapers are typically slower.

What to Expect During Tapering

Common withdrawal symptoms during proper tapering include 6:

  • Sleep disturbance and rebound insomnia (most common)
  • Increased tension and anxiety
  • Irritability
  • Hand tremor
  • Difficulty concentrating
  • Headache
  • Muscle pain and stiffness
  • Sweating

These symptoms are typically manageable with gradual tapering and usually last 10-14 days after complete discontinuation 6.

Critical Safety Considerations

Do not attempt this taper without medical supervision. Contact your prescribing physician to:

  1. Confirm the tapering schedule appropriate for your specific situation
  2. Monitor for withdrawal symptoms during the taper
  3. Address underlying anxiety with non-benzodiazepine alternatives if needed (such as SSRIs, cognitive behavioral therapy, or other evidence-based treatments) 1, 2

The risk is particularly elevated if you have 1:

  • History of seizures
  • Concurrent use of other CNS depressants (especially opioids)
  • Other medical comorbidities
  • Psychiatric conditions

Why This Matters

Research shows that benzodiazepine withdrawal carries greater risks than opioid withdrawal 1, 2. A recent systematic review found that benzodiazepine withdrawal delirium can occur 12 hours to 13 days after dose changes, with complete symptom resolution typically requiring reinitiation of the benzodiazepine followed by proper tapering 7.

The bottom line: Six weeks of daily lorazepam use is sufficient to cause physiological dependence. Work with your physician to implement a gradual taper over 6-8 weeks rather than stopping abruptly. This approach balances safety with the goal of discontinuation while minimizing withdrawal complications.

References

Guideline

prevention and control of seasonal influenza with vaccines.

MMWR Recommendations and Reports, 2016

Research

Benzodiazepine withdrawal seizures and management.

The Journal of the Oklahoma State Medical Association, 2011

Guideline

neonatal drug withdrawal.

Pediatrics, 2012

Research

The benzodiazepine withdrawal syndrome.

Addiction (Abingdon, England), 1994

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.